Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000260779

Medchemexpress LLC Atn-161 | 262438-43-7 | 99.4% | C23H35N9O8S | 10MG
SDP

Catalog No. 5000260779
Encompass_Preferred

ATN-161 is a novel integrin α5β1 antagonist peptide that inhibits angiogenesis and the growth of liver metastases in murine models. Supplied as a white to off-white solid for research use only, it has high chemical purity and defined storage and solubility properties suited for in vitro and in vivo experimental applications.

  • High purity suitable for research applications.
  • Peptide antagonist of integrin α5β1 with anti-angiogenic activity in vivo.
  • Available as a stable solid with recommended low-temperature storage.
  • Soluble in DMSO and water to facilitate assay preparation.
  • Intended for laboratory research use only; not for human use.

Catalog No. 50-002-60779 Supplier Medchemexpress LLC Supplier No. HY1353510MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ATN-161 is a novel integrin α5β1 antagonist peptide that inhibits angiogenesis and the growth of liver metastases in murine models. Supplied as a white to off-white solid for research use only, it has high chemical purity and defined storage and solubility properties suited for in vitro and in vivo experimental applications.

  • High purity suitable for research applications.
  • Peptide antagonist of integrin α5β1 with anti-angiogenic activity in vivo.
  • Available as a stable solid with recommended low-temperature storage.
  • Soluble in DMSO and water to facilitate assay preparation.
  • Intended for laboratory research use only; not for human use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.